Aureus Pharma signs knowledge-base licensing deal with GSK

13 February 2006

France's Aureus Pharma, a knowledge management provider for the life sciences industry, says it has signed a licensing deal with UK drug major GlaxoSmithKline which grants the latter access to Aureus' AurSCOPE Knowledge databases.

The deal covers several of the Parisian firm's datasets, including information on: AurSCOPE GPCR; Ion Channel hERG; and ADME/Drug-Drug Interactions. In addition, GSK has licensed Aureus AurSCOPE Kinase product for use in the field of oncology. Financial details were not disclosed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight